IPM Take
This is not a normal digital health story. It is a story about power. A mental health bedroom is not just a hospital room. It is where a person in crisis is supposed to be safe, vulnerable, protected and treated with dignity. If technology enters that room, the burden of proof must be high. Safety cannot become the language used to normalise surveillance. Mental health patients need more care, not fewer human eyes replaced by cameras.
Executive Summary
The Guardian reported that the UK Information Commissioner’s Office has launched an investigation into Oxevision, a camera and infrared monitoring system used in mental health patients’ bedrooms. The system is reportedly used by 40% of NHS mental health trusts and is being scrutinised over privacy and data protection concerns. Lawyers for the campaign group Stop Oxevision asked the ICO to examine how patient-derived data, including video images, are collected, processed and retained. The technology is also under scrutiny in the Lampard inquiry into deaths of mental health patients in Essex. Oxehealth, now rebranded as LIO, says the technology supports patient safety and staff awareness. Critics argue it can worsen distress, undermine privacy and be used as a substitute for in-person care.
Why it matters
- Patients: People in psychiatric crisis should not have to trade privacy and dignity for safety.
- Families: Technology that claims to protect patients must be independently tested, transparent and accountable when harm occurs.
- Health systems: Digital tools cannot become a cheaper substitute for staffing, therapeutic relationships and proper observation.
There are places where technology should enter only with humility.
A psychiatric bedroom is one of them.
The Oxevision investigation is powerful because it cuts through the usual language of innovation. The system is presented as a safety tool. But patients and families are asking something more basic: what happens to dignity when a person in crisis is watched in the place where they sleep?
This is not abstract. The Guardian reports the case of Sophie Alderman, who died by suicide in 2022 while under Oxevision surveillance. Her mother has said the system was intrusive, unsafe and contributed to her daughter’s paranoia. Lawyers and campaigners are asking whether the system has a clear lawful basis for collecting and retaining sensitive patient data.
The company argues that the technology can help staff identify serious risks. That argument must be heard. Acute psychiatric settings are difficult, dangerous and under pressure. Staff need tools that help them keep people alive.
But the political question remains: who decides when monitoring becomes surveillance?
Mental health care already carries a power imbalance. Patients can be detained. Doors can be locked. Treatment can be coercive. Adding cameras into bedrooms without full trust, clear consent and independent accountability risks deepening that imbalance.
For IPM, this is a digital health warning. Innovation in neuropsychiatry must be judged not only by efficiency or incident reduction, but by autonomy, dignity, consent and therapeutic trust.
A camera cannot replace care. And a system that makes patients feel watched, rather than held, may be solving the wrong problem.
